Quantitative Prediction of Formulation-specific Food Effects and Their Population Variability from In Vitro Data Using the Physiologically-based ADAM Model: A Case Study Using BCS/BDDCS Class II Drug Nifedipine. 論文 Quantitative Prediction of Formulation-specific Food Effects and Their Population Variability from In Vitro Data Using the Physiologically-based ADAM Model: A Case Study Using BCS/BDDCS Class II Drug Nifedipine. Quantitative prediction of food effects (FE) upon drug pharmacokinetics, including population variability, in advance of human trials may help with trial design by optimizing…Certara2014年6月16日
Conversion from Twice- to Once-daily Tacrolimus in Pediatric Kidney Recipients: A Pharmacokinetic and Bioequivalence Study Publication Conversion from Twice- to Once-daily Tacrolimus in Pediatric Kidney Recipients: A Pharmacokinetic and Bioequivalence Study The objectives of this study were to investigate pharmacokinetic and pharmacogenetic parameters during the conversion…Certara2014年6月1日
Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Pediatric Liver Transplant Recipients Publication Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Pediatric Liver Transplant Recipients Objectives of this study were to develop a population pharmacokinetic (PopPK) model for tacrolimus in…Certara2014年6月1日
Activities of Ceftazidime and Avibactam Against β-lactamase-producing Enterobacteriaceae in a Hollow-fiber Pharmacodynamic Model Publication Activities of Ceftazidime and Avibactam Against β-lactamase-producing Enterobacteriaceae in a Hollow-fiber Pharmacodynamic Model Avibactam is a novel non-β-lactam β-lactamase inhibitor that is currently undergoing phase 3 clinical trials…Certara2014年6月1日
The ISoP Standards and Best Practices Committee Publication The ISoP Standards and Best Practices Committee The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is…Certara2014年6月1日
The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach Publication The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach Certara2014年5月27日
Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Publication Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Model-based meta-analysis of dose response is a sophisticated method to guide dose and regimen selection.…Certara2014年5月21日
Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model Poster Modeling the Binding Kinetics of Bispecific Antibodies under the Framework of a Minimal Human PBPK Model Certara2014年5月19日
Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science Publication Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science Fourteen drugs have been removed from the market worldwide because they cause torsade de pointes.…Certara2014年5月1日
Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model Publication Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model Although both POPPK and physiologically based pharmacokinetic (PBPK) models can account for age and other covariates within…Certara2014年5月1日